"Our Mission says it all: To improve the health and well-being of Veterans through research and education conducted at the VA Puget Sound Health Care System."

During the past decade, Seattle Institute for Biomedical and Clinical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seattle Institute for Biomedical and Clinical Research" #1 collaborator was "Becton, Dickinson and Company" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Centers for Disease Control and Prevention" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Seattle Institute for Biomedical and Clinical Research" are "Comparative Effectiveness of Glycemia-lowering Medications" (1 trials), "Head and Neck Cancer" (1 trials), "Oral Complications" (1 trials), "Radiation Toxicity" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Seattle Institute for Biomedical and Clinical Research" in a lesser frequency.

Most popular intervention types in "Seattle Institute for Biomedical and Clinical Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DPP-4 inhibitor (sitagliptin)" (1 trials), "GLP-1 receptor agonist (liraglutide)" (1 trials), "Insulin (glargine)" (1 trials), "Sulfonylurea (glimepiride)" (1 trials) and "cevimeline hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seattle Institute for Biomedical and Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Seattle Institute for Biomedical and Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Seattle Institute for Biomedical and Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Seattle Institute for Biomedical and Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".